Andrew H Galligan
CIK 1417976 · Chief Financial Officer · last filed 2026-06-08
Andrew H Galligan is a Chief Financial Officer who has filed 55 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for OOMA, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$16.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.40M
3
55
-$16.57M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OOMA | Director | 250,824 | $17.55 | $4.40M | -$940.2K | 17 | 2026-06-08 |
| Arcellx, Inc. (ACLX) Delisted | Director | 0 | $115.07 | $0 | $0 | 3 | 2026-04-28 |
| NEVRO CORP (NVRO) Delisted | Chief Financial Officer | 59,179 | $5.84 | $345.6K | -$15.63M | 31 | 2020-06-08 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | OOMA | Grant (A) | +9,743 | $0 | EDGAR |
| 2026-04-28 | Arcellx, Inc. (ACLX) Delisted | Mixed | −5,000 | $0 | EDGAR |
| 2025-06-24 | OOMA | Sell (S) | −12,407 | -$154.3K | EDGAR |
| 2025-06-09 | OOMA | Grant (A) | +11,556 | $0 | EDGAR |
| 2025-05-30 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-03-20 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-19 | OOMA | Mixed | +20,176 | -$4.4K | EDGAR |
| 2024-06-07 | OOMA | Grant (A) | +19,762 | $0 | EDGAR |
| 2023-06-05 | OOMA | Grant (A) | +11,783 | $0 | EDGAR |
| 2022-06-03 | OOMA | Grant (A) | +11,355 | $0 | EDGAR |